Mobilization of natural killer cells inhibits development of collagen-induced arthritis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 35, 2011, Pages 14584-14589

  Leavenworth, Jianmei W ^a,b   Wang, Xiaoyang ^a,b,c,d   Wenander, Carola Schellack ^e   Spee, Pieter ^e   Cantor, Harvey ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d ZHENGZHOU UNIVERSITY   (China)

^e NOVO NORDISK A S   (Denmark)

Author keywords

Antibody therapy; Qa 1; T helper subsets

Indexed keywords

CD94 RECEPTOR; PERFORIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MOTILITY; COLLAGEN INDUCD ARTHRITIS; CONTROLLED STUDY; DISEASE COURSE; HELPER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TH17 CELL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL COMMUNICATION; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; TH1 CELLS; TH17 CELLS;

EID: 80052279550     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1112188108     Document Type: Article

References (20)

1. Gabriel S.E., Michaud K. (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229.
2. Cho Y.G., Cho M.L., Min S.Y., Kim H.Y. (2007) Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 7:65-70.
3. Asquith D.L., Miller A.M., McInnes I.B., Liew F.Y. (2009) Animal models of rheumatoid arthritis. Eur J Immunol 39:2040-2044.
4. Bevaart L., Vervoordeldonk M.J., Tak P.P. (2010) Evaluation of therapeutic targets in animal models of arthritis:How does it relate to rheumatoid arthritis? Arthritis Rheum 62:2192-2205.
5. Leipe J., et al. (2010) Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62:2876-2885.
6. Vinuesa C.G., Tangye S.G., Moser B., Mackay C.R. (2005) Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 5:853-865. (Pubitemid 41581667)
7. Crotty S. (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621-663.
8. Lu L., et al. (2007) Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26:593-604. (Pubitemid 46756350)
9. Leavenworth J.W., et al. (2010) Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab′)2. Proc Natl Acad Sci USA 107: 2562-2567.
10. Kim H.J., et al. (2011) CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci USA 108:2010-2015.
11. Dalbeth N., Callan M.F. (2002) A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 46:1763-1772.
12. de Matos CT, et al. (2007) Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: Role of CD94/NKG2A in control of cytokine secretion. Immunology 122:291-301.
13. Schuna A.A., Megeff C. (2000) New drugs for the treatment of rheumatoid arthritis. Am J Health Syst Pharm 57:225-234.
14. Schuna A.A. (2007) Rituximab for the treatment of rheumatoid arthritis. Pharmacotherapy 27:1702-1710.
15. Kim H.J., Verbinnen B., Tang X., Lu L., Cantor H. (2010) Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature 467:328-332.
16. Rowley M.J., Nandakumar K.S., Holmdahl R. (2008) The role of collagen antibodies in mediating arthritis. Mod Rheumatol 18:429-441.
17. O'Shea J.J., Paul W.E. (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327:1098-1102.
18. Ahern D.J., Brennan F.M. (2011) The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis:Major contributors or essential homeostatic modulators? Immunol Lett 136:115-121.
19. Dalbeth N., et al. (2004) CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 173: 6418-6426. (Pubitemid 39487802)
20. Aramaki T., et al. (2009) Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables. Mod Rheumatol 19:652-656.